Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling.
Zhong J, He X, Gao X, Liu Q, Zhao Y, Hong Y, Zhu W, Yan J, Li Y, Li Y, Zheng N, Bao Y, Wang H, Ma J, Huang W, Liu Z, Lyu Y, Ke X, Jia W, Xie C, Hu Y, Sheng L, Li H.
Zhong J, et al.
Nat Commun. 2023 Sep 6;14(1):5451. doi: 10.1038/s41467-023-41061-8.
Nat Commun. 2023.
PMID: 37673856
Free PMC article.